Women younger than 25 years are at greatest risk for human papillomavirus (HPV) infection, including high-risk strains associated with 70% of cervical cancers. Effective model-based measures that can lead to intervention development to increase HPV vaccination rates are necessary. This study validated Transtheoretical Model measures of Decisional Balance and Self-Efficacy for seeking the HPV vaccine in a sample of female college students.
Design.
Cross-sectional measurement development.
Setting.
Online survey of undergraduate college students.
Subjects.
A total of 340 female students ages 18 to 26 years.
Measures.
Stage of Change, Decisional Balance, and Self-Efficacy.
Analysis.
The sample was randomly split into halves for exploratory principal components analyses (PCAs), followed by confirmatory factor analyses (CFAs) to test measurement models. Multivariate analyses examined relationships between constructs.
Results.
For Decisional Balance, PCA indicated two 4-item factors (Pros –α = .90; and Cons –α = .66). CFA supported a two-factor correlated model, χ2(19) = 39.33; p < .01; comparative fit index (CFI) = .97; and average absolute standardized residual statistic (AASR) = .03; with Pros α = .90 and Cons α = .67. For Self-Efficacy, PCA indicated one 6-item factor (α = .84). CFA supported this structure, χ2(9) = 50.87; p < .05; CFI = .94; AASR = .03; and α = .90. Multivariate analyses indicated significant cross-stage differences on Pros, Cons, and Self-Efficacy in expected directions.
Conclusion.
Findings support the internal and external validity of these measures and their use in Transtheoretical Model–tailored interventions. Stage-construct relationships suggest that reducing the Cons of vaccination may be more important for HPV than for behaviors with a true Maintenance stage.
MyersERMcCroryDCNandaK. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000;151:1158–1171.
3.
BasemanJGKoutskyLA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32(suppl): S16–S24.
4.
DunneEFUngerERSternbergM. Prevalence of HPV infection among females in the United States. JAMA. 2007;297:813–819.
5.
TrottierHFrancoEL. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;24:4–15.
6.
KoutskyL. Epidemiology of genital human papillomavirus infection. Am J Med.1997;102:3–8.
7.
FUTURE II Study Group.Quadrivalent human papillomavirus to prevent high-grade cervical lesions. N Engl J Med.2007;356:1915–1927.
CasperMJCarpenterLM. Sex, drugs, and politics: The HPV vaccine for cervical cancer. Sociol Health Illn.2008;30:886–899.
10.
Centers for Disease Control and Prevention.National, state, and local area vaccination coverage among adolescents aged 13–17 years – United States, 2009. MMWR Morb Mortal Wkly Rep.2010;59:1018–1023.
HoGYBiermanRBeardsleyL. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med.1998;338:423–428.
13.
WinerRLHughesJPFengQ. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med.2006;354:2645–2654.
14.
AllenJDMohllajeeAPSheltonRC. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med.2009;48:420–425.
15.
LichtASMurphyJMHylandAJ. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?Sex Transm Infect. 2010;86:74–78.
16.
JainNEulerGLSheferA. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey–Adult 2007. Prev Med.2009;48:426–431.
17.
BrewerNTFazekasKI. Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med.2007;45:107–114.
18.
FernandezMEAllenJDMistryRKahnJA. Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Ann Rev Public Health. 2010;31:235–252.
19.
ProchaskaJODiClementeCC. Stages and processes of self-change of smoking: Toward an integrative model of change. J Consult Clin Psychol. 1983;51:390–395.
20.
RakowskiWDubeCAGoldsteinMG. Considerations for extending the transtheoretical model of behavior change to screening mammography. Health Educ Res.1996;11:77–96.
21.
HallKLRossiJS. Meta-analytic examination of the strong and weak principles across 48 health behaviors. Prev Med.2008;46:266–274.
22.
JohnsonSSDriskellMMJohnsonJL. Transtheoretical model intervention for adherence to lipid-lowering drugs. Dis Manag. 2006;9:102–114.
23.
LarsonHEBlaneyCKobayashiH. HPV knowledge and stages of change measure for HPV vaccine completion among college women [abstract]. Ann Behav Med.2011;41(S1):S199
24.
BurdittCRobbinsMLPaiveA. Motivation for blood donation among African Americans: Developing measures for stage of change, decisional balance, and self-efficacy constructs. J Behav Med.2009;32:429–442.
25.
VelicerWFDiClementeCCProchaskaJOBrandenburgN. Decisional balance measure for assessing and predicting smoking status. J Pers Soc Psychol. 1985;48:1279–1289.
26.
VelicerWFDiclementeCCRossiJSProchaskaJO. Relapse situation and self-efficacy: An integrative model. Addict Behav. 1990;15:271–283.
27.
RossiJSReddingCA. Structure and function of self-efficacy across the stages of change for 10 health behaviors [abstract]. Ann Behav Med.2001;23S:S94.
28.
ReddingCAMaddockJERossiJS. The sequential approach to measurement of health behavior constructs: Issues in selecting and developing measures. Cal J Health Promot. 2006;4:83–101.
29.
JacksonDN. The dynamics of structured personality tests. Psychol Rev.1971;78:229–248.
30.
JacksonDN. A sequential system for personality scale development. In: SpeilbergerCD, ed. Curent Topics in Clinical and Community Psychology. No. 2. New York, NY: Academic Press; 1970:61–96.
31.
KlineRB. Principles and Practice of Structural Equation Modeling. 3rd ed.New York, NY: Guilford Press; 2010.
32.
GuadagnoliEVelicerW. A comparison of pattern matching indices. Multivariate Behav Res.1991;26:323–343.
33.
VelicerWF. The relation between factor score estimates, image scores and principal component scores. Educ Psychol Meas. 1976;36:149–159.
34.
HornJL. A rationale and tests for the number of factors in factor analysis. Psychometrika. 1965;30:179–185.
35.
ZwickWRVelicerWF. Comparison of five rules for determining the number of components to retain. Psychol Bull.1986;99:432–442.
ProchaskaJOVelicerWFRossiJS. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13:39–46.
38.
SarkinJAJohnsonSSProchaskaJOProchaskaJM. Applying the transtheoretical model to regular moderate exercise in an overweight population: Validation of a stages of change measure. Prev Med.2001;33:462–469.
39.
LingAMCHorwathC. Perceived benefits and barriers of increased fruit and vegetable consumption: Validation of a decisional balance scale. J Nutr Educ.2001;33:257–265.
40.
ProchaskaJO. Strong and weak principles for progressing from precontemplation to action on the basis of twelve problem behaviors. Health Psychol. 1994;13:1–5.
41.
VelicerWFNormanGJFavaJLProchaskaJO. Testing 40 predictions from the transtheoretical model. Addictive Behaviors. 1999;24(4):455–469.
42.
KrebsPProchaskaJORossiJS. A meta-analysis of computer-tailored interventions for health behavior change. Prev Med.2010;51:214–221.
43.
NoarSMBenacCNHarrisMS. Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychol Bull.2007;133:673–693.
